Results 71 to 80 of about 136,379 (287)

Papillary Renal Cell Carcinoma [PDF]

, 2020
null Erick M. Remer, MD, null Alexander D. Christie, MD   +1 more
  +6 more sources

Determination of angptl4 mRNA as a diagnostic marker of primary and metastatic clear cell renal-cell carcinoma. [PDF]

PLoS ONE, 2010
BackgroundWe have previously shown that angiopoietin-like 4 (angptl4) mRNA, a hypoxia-inducible gene, is highly expressed in clear cell renal-cell carcinoma (ccRCC), the most common subtype of RCC for which no specific marker is available.
Jérôme Verine, Jacqueline Lehmann-Che, Hany Soliman, Jean-Paul Feugeas, Jean-Sébastien Vidal, Pierre Mongiat-Artus, Stéphanie Belhadj, Josette Philippe, Matthieu Lesage, Evelyne Wittmer, Stéphane Chanel, Anne Couvelard, Sophie Ferlicot, Nathalie Rioux-Leclercq, Jean-Michel Vignaud, Anne Janin, Stéphane Germain   +16 more
doaj   +1 more source

Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma [PDF]

Human Pathology, 2014
Clear cell papillary renal cell carcinoma (CCPRCC) is a low-grade renal neoplasm with morphological characteristics mimicking both clear cell renal cell carcinoma (CCRCC) and papillary renal cell carcinoma (PRCC). However, despite some overlapping features, their morphological, immunohistochemical, and molecular profiles are distinct.
Munari E, Marchionni L, Chitre A, Hayashi M, MARTIGNONI, Guido, BRUNELLI, Matteo, Argani P, Allaf M, Hoque MO, Netto GJ, Gobbo S   +10 more
openaire   +3 more sources

The Role of SAMHD1 in Viral Resistance and Transduction Efficiency Challenges in Pediatric Hematological Malignancies: Mechanistic Insights and Clinical Perspectives

European Journal of Haematology, EarlyView.
SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley   +1 more source

Identification of a novel methylation gene sites signature to predict prognosis in kidney renal papillary cell carcinoma by comprehensive profiling [PDF]

, 2020
Yinglei Wang, Yingying Zhang
openalex   +1 more source

Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in papillary renal cell carcinoma patients after receiving curative surgery based on a retrospective cohort [PDF]

, 2021
Zhilei Zhang, Yongbo Yu, Jilu Zheng, Mingxin Zhang, Haitao Niu   +4 more
openalex   +1 more source

Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features

Histopathology, EarlyView.
Papillary renal cell carcinoma (pRCC) accounts for 15%–20% of RCC cases and is the second most common histologic subtype of RCC. In contrast to other common RCC subtypes, there continues to be ongoing debate about how to classify RCCs with papillary architecture and eosinophilic cytoplasm, given the heterogeneity of histologic, IHC and molecular ...
Melissa Yuwono Tjota, Jung Woo Kwon, Pankhuri Wanjari, Tatjana Antic   +3 more
wiley   +1 more source

Diagnosing oncocytic renal tumours on renal mass biopsy; pathological concordance and the impact of evolving classification

Histopathology, EarlyView.
Overall, there was good concordance between renal mass biopsy and subsequent diagnosis at nephrectomy or repeat biopsy in oncocytic renal neoplasms. Some discordant cases were reclassified as emerging tumour entities (LOT, EVT), indicating that greater recognition of these entities may help reduce diagnostic uncertainty and improve biopsy ...
Shifaa' Al Qa'qa', Carol C Cheung, Satheesh Krishna, Antonio Finelli, Susan Prendeville   +4 more
wiley   +1 more source

Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling

eLife, 2016
TFE-fusion renal cell carcinomas (TFE-fusion RCCs) are caused by chromosomal translocations that lead to overexpression of the TFEB and TFE3 genes (Kauffman et al., 2014).
Alessia Calcagnì, Lotte kors, Eric Verschuren, Rossella De Cegli, Nicolina Zampelli, Edoardo Nusco, Stefano Confalonieri, Giovanni Bertalot, Salvatore Pece, Carmine Settembre, Gabriel G Malouf, Jaklien C Leemans, Emile de Heer, Marco Salvatore, Dorien JM Peters, Pier Paolo Di Fiore, Andrea Ballabio   +16 more
doaj   +1 more source

The spectrum of breast in situ papillary carcinomas with invasion and invasive breast carcinomas with papillary features: an overview of histological subtypes and diagnostic challenges

Histopathology, EarlyView.
Invasive breast carcinomas with papillary features (IBCP) comprise diverse subtypes with variable architecture, histopathology, and clinical behaviour. This review outlines evolving classification, diagnostic criteria, and treatment implications, highlighting challenges in distinguishing in situ from invasive lesions. Standardised diagnostic approaches
Emad A Rakha, Puay Hoon Tan, Wendy A Raymond   +2 more
wiley   +1 more source